These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38138618)

  • 1. Glycyrrhetinic Acid Receptor-Mediated Zeolitic Imidazolate Framework-8 Loaded Doxorubicin as a Nanotherapeutic System for Liver Cancer Treatment.
    Mi X; Lou Y; Wang Y; Dong M; Xue H; Li S; Lu J; Chen X
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer.
    Yang T; Lan Y; Cao M; Ma X; Cao A; Sun Y; Yang J; Li L; Liu Y
    Colloids Surf B Biointerfaces; 2019 Mar; 175():106-115. PubMed ID: 30529816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced delivery of doxorubicin to the liver through self-assembled nanoparticles formed via conjugation of glycyrrhetinic acid to the hydroxyl group of hyaluronic acid.
    Wang X; Gu X; Wang H; Yang J; Mao S
    Carbohydr Polym; 2018 Sep; 195():170-179. PubMed ID: 29804965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-Ligand-Functionalized Liposomes Based on Glycyrrhetinic Acid and cRGD for Hepatocellular Carcinoma Targeting and Therapy.
    Qiu M; Wang J; Bai J; Li X; Tian C; Liu Z; Zheng C; Clark AR; Cheng X; Liao X; Wu S; Lee RJ; Zhou X
    Mol Pharm; 2023 Apr; 20(4):1951-1963. PubMed ID: 36952242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
    Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
    Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zeolitic Imidazolate Framework (ZIF-8) Decorated Iron Oxide Nanoparticles Loaded Doxorubicin Hydrochloride for Osteosarcoma Treatment - in vitro and in vivo Preclinical Studies.
    Wu W; Yu X; Sun J; Han Y; Ma Y; Zhang G; Ma Q; Li Q; Xiang H
    Int J Nanomedicine; 2023; 18():7985-7999. PubMed ID: 38164268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleavable Multifunctional Targeting Mixed Micelles with Sequential pH-Triggered TAT Peptide Activation for Improved Antihepatocellular Carcinoma Efficacy.
    Zhang J; Zheng Y; Xie X; Wang L; Su Z; Wang Y; Leong KW; Chen M
    Mol Pharm; 2017 Nov; 14(11):3644-3659. PubMed ID: 28994600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy.
    Zhang C; Wang W; Liu T; Wu Y; Guo H; Wang P; Tian Q; Wang Y; Yuan Z
    Biomaterials; 2012 Mar; 33(7):2187-96. PubMed ID: 22169820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal-organic framework decorated with glycyrrhetinic acid conjugated chitosan as a pH-responsive nanocarrier for targeted drug delivery.
    Cui L; Wang X; Liu Z; Li Z; Bai Z; Lin K; Yang J; Cui Y; Tian F
    Int J Biol Macromol; 2023 Jun; 240():124370. PubMed ID: 37044320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
    Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N
    Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin.
    Du H; Liu M; Yu A; Ji J; Zhai G
    Int J Pharm; 2017 May; 523(1):427-438. PubMed ID: 28359815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy.
    Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q
    Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent multifunctional ZIF-8 nanoplatform developed for colorectal cancer therapy by triple-delivery of chemo/radio/targeted therapy agents.
    Iranpour S; Bahrami AR; Dayyani M; Saljooghi AS; Matin MM
    J Mater Chem B; 2024 Jan; 12(4):1096-1114. PubMed ID: 38229578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Size-shrinkable and protein kinase Cα-recognizable nanoparticles for deep tumor penetration and cellular internalization.
    Ma JB; Shen JM; Yue T; Wu ZY; Zhang XL
    Eur J Pharm Sci; 2021 Apr; 159():105693. PubMed ID: 33383133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
    Tian Q; Zhang CN; Wang XH; Wang W; Huang W; Cha RT; Wang CH; Yuan Z; Liu M; Wan HY; Tang H
    Biomaterials; 2010 Jun; 31(17):4748-56. PubMed ID: 20303163
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Diril M; Özdokur KV; Yıldırım Y; Karasulu HY
    Pharm Dev Technol; 2023 Dec; 28(10):915-927. PubMed ID: 37921920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Reactive Oxygen Species Generation by Mitochondria Targeting of Anticancer Drug To Overcome Tumor Multidrug Resistance.
    Liu Y; Zhou Z; Lin X; Xiong X; Zhou R; Zhou M; Huang Y
    Biomacromolecules; 2019 Oct; 20(10):3755-3766. PubMed ID: 31465208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional alginate nanoparticles for efficient intracellular release of doxorubicin and hepatoma carcinoma cell targeting therapy.
    Guo H; Lai Q; Wang W; Wu Y; Zhang C; Liu Y; Yuan Z
    Int J Pharm; 2013 Jul; 451(1-2):1-11. PubMed ID: 23618965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic Acid Decorated Zeolitic Imidazolate Framework (ZIF-8) Loaded with Baicalin as a Nano-Drug Delivery System for Breast Cancer Therapy.
    Mi X; Hu M; Dong M; Yang Z; Zhan X; Chang X; Lu J; Chen X
    Int J Nanomedicine; 2021; 16():8337-8352. PubMed ID: 34992370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Codelivery of Doxorubicin and shAkt1 by Poly(ethylenimine)-Glycyrrhetinic Acid Nanoparticles To Induce Autophagy-Mediated Liver Cancer Combination Therapy.
    Wang FZ; Xing L; Tang ZH; Lu JJ; Cui PF; Qiao JB; Jiang L; Jiang HL; Zong L
    Mol Pharm; 2016 Apr; 13(4):1298-307. PubMed ID: 26894988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.